TIBIAL FRACTURE IN AN ELDERLY FEMALE PATIENT OF RHEUMATOID ARTHRITIS: A PREVENTABLE IATROGENIC INJURY
Oral systemic glucocorticoids widely used in the medical practice to treat various diseases like asthma, systemic connective tissue diseases, other autoimmune diseases and in transplantology, are considered the main cause of secondary and iatrogenic osteoporosis. The pathogenesis of glucocorticoid-induced bone loss is multifactorial and complex. The exact mechanism remains undefined. The present report describes a case of 65 years old female presenting with a fracture in midshaft of the tibia after a very low-velocity trauma. On medical history elicitation, she was found to be treated for rheumatoid arthritis with oral glucocorticoids. Causality, severity and preventability assessment was done for the reaction. The potentiality of glucocorticoids causing fractures is often neglected by professionals and ignored by the patient and their caregivers. Given the potential for rapid bone loss with glucocorticoid therapy, frequent monitoring is warranted while bearing in mind that BMD is a surrogate marker for fracture risk and patients on glucocorticoids fracture at higher BMD than other patients. Once treatment is initiated, BMD should be monitored annually to ensure compliance and efficacy.
How to Cite
Copyright (c) 2019 Shambo Samrat Samajdar, Shatavisa Mukherjee, Sumalya Sen, Santanu Kumar Tripathi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.